ProVise Management Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-939
Closed -$267K 336
2023
Q2
$267K Hold
939
0.02% 296
2023
Q1
$261K Hold
939
0.03% 298
2022
Q4
$260K Sell
939
-561
-37% -$158K 0.03% 274
2022
Q3
$401K Hold
1,500
0.04% 224
2022
Q2
$306K Buy
1,500
+488
+48% +$99.8K 0.03% 252
2022
Q1
$213K Buy
+1,012
New +$220K 0.02% 349
2016
Q2
Sell
-900
Closed -$234K 304
2016
Q1
$234K Sell
900
-200
-18% -$52.8K 0.05% 252
2015
Q4
$337K Buy
+1,100
New +$316K 0.07% 221
2014
Q2
Sell
-932
Closed -$285K 310
2014
Q1
$285K Sell
932
-245
-21% -$77.8K 0.07% 239
2013
Q4
$329K Buy
1,177
+75
+7% +$19.4K 0.08% 223
2013
Q3
$265K Sell
1,102
-20
-2% -$4.48K 0.08% 256
2013
Q2
$241K Buy
+1,122
New +$240K 0.07% 273

Other funds holding BIIB